Table S1. Demographic and clinical characteristics of the MS patients with benign and aggressive disease courses. Figure S1. IGSF9B expression levels in PBMC from MS patients stratified according to the genetic variant associated with disease course. Figure S2. GTEx eQTLs of rs10894768 associations with IGSF9B expression in thyroid and pancreas tissues. (DOC 551 kb
Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from pr...
Table S1. Case/control datasets included in the study. Table S2. Loci reaching genome-wide level of ...
Eligible SNPs from literature for the replication. The information extracted for 526 SNPs in 109 loc...
Background: It remains unclear whether disease course in multiple sclerosis (MS) is...
BackgroundIt remains unclear whether disease course in multiple sclerosis (MS) is influenced by gene...
Table S1. Exome sequencing significant (p < 0.005) results generated by comparing MS patients respon...
Figure S1. eQTL data of MS risk variants in whole blood (A) and LCLs (B). Figure S2. Identifying gen...
PCR primers used to verify gene expression of SNP-containing regions of the indicated genes in whole...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...
Table S8. Correlation between MS genetic burden and MS risk loci with levels of phosphorylated prote...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
Table S1. Genes dysregulated due to EBV infection. Table S2. LCLeQTL gene list. Table S3. Replicatio...
Table S3. Subclusters of genes/probes showing the most differential expression patterns between TMEV...
Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from pr...
Table S1. Case/control datasets included in the study. Table S2. Loci reaching genome-wide level of ...
Eligible SNPs from literature for the replication. The information extracted for 526 SNPs in 109 loc...
Background: It remains unclear whether disease course in multiple sclerosis (MS) is...
BackgroundIt remains unclear whether disease course in multiple sclerosis (MS) is influenced by gene...
Table S1. Exome sequencing significant (p < 0.005) results generated by comparing MS patients respon...
Figure S1. eQTL data of MS risk variants in whole blood (A) and LCLs (B). Figure S2. Identifying gen...
PCR primers used to verify gene expression of SNP-containing regions of the indicated genes in whole...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...
Table S8. Correlation between MS genetic burden and MS risk loci with levels of phosphorylated prote...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
Table S1. Genes dysregulated due to EBV infection. Table S2. LCLeQTL gene list. Table S3. Replicatio...
Table S3. Subclusters of genes/probes showing the most differential expression patterns between TMEV...
Table S2. Shows all causative mutations identified in 72 patients from 68 families suffering from pr...
Table S1. Case/control datasets included in the study. Table S2. Loci reaching genome-wide level of ...
Eligible SNPs from literature for the replication. The information extracted for 526 SNPs in 109 loc...